Yueyong Zhu

机构：Fujian Medical University, Kunming Medical University, Fudan University Shanghai Cancer Center, Anhui Business College, First Affiliated Hospital of Fujian Medical University, Yan'an Hospital Affiliated To Kunming Medical University, West Anhui University · ORCID：0000-0002-0746-4911

发表论文 164 篇 · 总被引 3585 次 · h-index 33

代表论文

• A global survey on the use of the international classification of diseases codes for metabolic dysfunction-associated fatty liver disease (2024 · Hepatology International · 被引 33)
• Varied immune responses of HBV-specific B cells in patients undergoing pegylated interferon-alpha treatment for chronic hepatitis B (2024 · Journal of Hepatology · 被引 29)
• Chiglitazar in MASLD with hypertriglyceridemia and insulin resistance: A phase II, randomized, double-blind, placebo-controlled study (2025 · Hepatology · 被引 10)
• Metabolic dysfunction-associated fatty liver disease increases the risk of complications after radical resection in patients with hepatocellular carcinoma (2024 · World Journal of Surgical Oncology · 被引 6)
• The PKHD1 gene inhibits tumor proliferation and invasion in intrahepatic cholangiocarcinoma by activating the Notch pathway (2024 · International Journal of Medical Sciences · 被引 5)
• A comprehensive meta-analysis of stem cell therapy for liver failure: Assessing treatment efficacy and modality (2024 · Annals of Hepatology · 被引 4)